Concord Asset Management (Virginia)’s Pfizer PFE Stock Holding History

Concord Asset Management (Virginia)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	43,466 -105	-0.2%	-$2.75K	0.16%	97
2026 Q1	$1.22M	Buy	43,571 +1,802	+4%	+$48K	0.21%	89
2025 Q4	$1.04M	Sell	41,769 -141	-0.3%	-$3.56K	0.18%	99
2025 Q3	$1.07M	Sell	41,910 -2,611	-6%	-$64.4K	0.19%	97
2025 Q2	$1.08M	Sell	44,521 -3,711	-8%	-$86.5K	0.16%	126
2025 Q1	$1.08M	Buy	48,232 +35,021	+265%	+$916K	0.24%	88
2024 Q4	$350K	Buy	+13,211	New	+$358K	0.08%	114
2023 Q1	–	Sell	-5,101	Closed	-$261K	–	113
2022 Q4	$261K	Buy	+5,101	New	+$245K	0.18%	44

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Concord Asset Management (Virginia)'s PFE Position: Q2 2026 in Review

Concord Asset Management (Virginia) reduced its Pfizer (PFE) stake by 0.24% in Q2 2026, selling an estimated $2.75K and leaving 43,466 shares worth $1.05M. The position accounts for 0.16% of the portfolio, ranked #97.

Concord Asset Management (Virginia) first reported a position in PFE in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.22M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Concord Asset Management (Virginia) held 43,466 shares of Pfizer worth $1.05M as of Q2 2026.
Concord Asset Management (Virginia) sold 105 Pfizer shares in Q2 2026, an estimated $2.75K.
Pfizer made up 0.16% of Concord Asset Management (Virginia)'s portfolio in Q2 2026, its #97 holding.
Concord Asset Management (Virginia) first reported a position in Pfizer in Q4 2022 and has held it in 8 quarters since.
Concord Asset Management (Virginia)'s Pfizer position peaked at $1.22M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q2 2026, filed 27 Jul 2026.